Generate a tailored SOP for Dr. Fabrice Jaffré. Improve your application with a focused, well-structured draft.
Fabrice Jaffré obtained his PhD from Sorbonne University Paris, where he explored the function of serotonin receptors in pathological cardiac hypertrophy. He joined Beth Israel Deaconess Medical Center at Harvard Medical School, utilizing human induced pluripotent stem cells (hiPSCs) to delineate molecular mechanisms underlying hypertrophic cardiomyopathy and RASopathies, with support from the Scientist Development Grant of the American Heart Association. After moving to New York City, he started an independent lab at Weill Cornell Medical College, where he received an NIH R56 grant from the National Heart, Lung, and Blood Institute. In September 2024, he joined the Australian Regenerative Medicine Institute, where his lab focuses on human iPSCs, cardiac directed differentiation, genome editing (including CRISPR), multi-omics, and 3D organoids to engineer heart tissues for developmental disease models. His current research is supported by the Additional Ventures Single Ventricle Research Fund Award.
Australian Regenerative Medicine Institute • Melbourne, Australia
Leading research on human iPSC-derived cardiomyocytes to investigate congenital heart defects.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.